ENVALITH
トレンダーズ株式会社 logo

Trenders, Inc.

6069Growth MarketServices

トレンダーズ株式会社 logo
Trenders, Inc.6069

Marketing Business

Core business providing integrated marketing support for corporations, centered on SNS marketing

PeriodCurrentPreviousChange
Net sales¥7,690 million¥5,995 million
Segment profit¥560 million¥963 million
Segment profit margin7.3%16.1%
Depreciation and amortization¥37 million¥36 million
Goodwill amortization¥81 million¥18 million
Goodwill balance (period-end)¥579 million¥681 million
Impairment loss¥79 million¥20 million

Business Details

The Marketing Business consists of two areas: the "Marketing Domain" and the "Medical Domain." In the Marketing Domain, the company provides marketing support through SNS-first integrated planning, operating Influencer Marketing, a beauty media platform (Mimi Beauty), and Comprehensive Event Production (zenplus). In the Medical Domain, the company provides marketing support for elective medical clinics. In FY2026 (ending March 2026), existing services struggled due to intensifying competition and platform-related factors, and combined with increased costs from new consolidations, segment profit declined significantly.

Recent Overview

Net sales rose 28.3% year on year, but segment profit fell 41.9% due to struggling existing services and increased costs

In the Marketing Business for FY2026 (ending March 2026), net sales expanded to ¥7,690 million (up 28.3% year on year), driven by the contribution from the new consolidation of zenplus. On the other hand, Influencer Marketing and Mimi Beauty saw sales and gross profit fall short of forecasts due to intensifying competition and platform-related factors, and combined with an increase in selling, general and administrative expenses associated with the new consolidation, segment profit deteriorated significantly to ¥560 million (down 41.9% year on year). Goodwill amortization also surged from ¥18 million in the prior period to ¥81 million, and an impairment loss of ¥79 million was recorded.

Key Products

service
Influencer Marketing

Marketing support that appeals to consumers on behalf of corporate products and services through influencers, based on SNS-first integrated planning. Due to intensifying competition and platform-related factors, sales and gross profit in FY2026 (ending March 2026) fell short of forecasts.

platform
Mimi Beauty

A web media specializing in the beauty domain. During FY2025 (ended March 2025), the company established a subsidiary, Mimi Beauty Co., Ltd., and transferred the business to it. In FY2026 (ending March 2026), sales and gross profit fell short of forecasts due to intensifying competition and platform-related factors.

service
Comprehensive Event Production (zenplus)

A comprehensive event production service provided by zenplus Co., Ltd., which became a subsidiary at the end of FY2025 (ended March 2025). Starting from FY2026 (ending March 2026), its income statement has been consolidated, providing three-dimensional marketing solutions that combine SNS marketing with real events.

service
Medical Marketing Support

A service in the Medical Domain that provides marketing support for elective medical clinics, centered on patient acquisition and branding support for clinics utilizing SNS.

Growth Drivers

  • Continued expansion of the internet advertising market (2025 market size: up 10.8% year on year, accounting for 50.2% of Japan's total advertising expenditure)
  • Accelerating demand for SNS-based marketing (growing trend of corporations focusing on SNS marketing)
  • Provision of three-dimensional solutions linking real events with SNS marketing through synergies with zenplus
  • Expansion of the customer base through development of categories beyond the beauty domain
  • Development of integrated SNS x EC mall marketing through collaboration with the EC Consulting Business (Shirushi Group)

Risks

  • Downside risk to sales and gross profit for Influencer Marketing and Mimi Beauty due to intensifying competition
  • Business impact from SNS platform-related factors (such as algorithm changes)
  • Pressure on profit from increased selling, general and administrative expenses associated with new consolidations (such as zenplus)
  • Downward pressure on profit from increased goodwill amortization burden (¥81 million in FY2026 (ending March 2026), approximately 4.5 times the prior period)
  • Risk of recording impairment losses on fixed assets in the Marketing Business segment (¥79 million recorded in FY2026 (ending March 2026))
  • Risk of delayed monetization in the Medical Marketing domain

Last updated: June 30, 2026